Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Amneal Pharmaceuticals, Inc. offers strong growth prospects with undervalued stock, rising revenues, reduced debt, and key ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

Tirzepatide is available through both the type 2 diabetes medication Mounjaro and weight-loss medication Zepbound. A new study funded by Eli Lilly reports that people without diabetes can lose up ...

Even a little weight loss can work wonders for your health. A study found that people at high risk for developing type 2 diabetes who lost 5-7% of their weight had a 58% lower risk of developing it.

When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously a ...

Novo Nordisk (NVO) markets Ozempic and Wegovy injections and Eli Lilly (LLY) markets its own injectable weight-loss drug as Zepbound. Hims & Hers (HIMS) is a compounder of the weight loss drug ...

To Hit 50% Of Adults By 2050 Says New Report Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss Novo Nordisk Faces Investor Concerns Over Hybrid ...